Owino B O, Oyoo G O, Otieno C F
Kenyatta National Hospital, P.O. Box 20723-00202, Nairobi, Kenya.
East Afr Med J. 2009 May;86(5):204-11. doi: 10.4314/eamj.v86i5.54190.
To determine the socio-demographic profiles and some clinical aspects of patients with rheumatoid arthritis (RA).
Prospective, cross-sectional study.
Ambulatory out- patient clinics of Kenyatta National Hospital (KNH), a public national and referral hospital.
Out of 180 patients interviewed and examined, 60 met American College of Rheumatology (ACR) diagnostic criteria of RA.
Of the 60 patients recruited 52 (87%) were females with male: female ratio of 1: 6.5. The mean age of patients was 41.38(+/- 16.8) years. There were two peaks of age of occurrence, 20-29 and 40-49 years. In 75% of the study patients, one or more of metacarpophalangeal joints of the hand were involved in the disease. Other frequently involved sites were--wrists, elbows, knees, ankles and glenohumeral joints of shoulders in a symmetrical manner. Serum rheumatoid factor was positive in 78.9% while rheumatoid nodules were present in 13.3% of the study patients. A large majority of patients (88%) had active disease with 18% having mild disease, 38% moderate activity and 32% having severe disease. Only 12% of patients had disease in remission. Forty six point seven per cent (46.7%) of the study patients were on at least one Disease Modifying anti Rheumatic Drugs (DMARD) from a selection of methotrexate, sulphasalazine, hydroxychloroquine and leflunamide. The most frequent drug combination was methotrexate plus prednisolone at 30% of the study population; while 66.7% were on oral prednisolone with 25% of the study patients taking only Non-Steroidal anti Inflammatory Drugs (NSAIDS).
A large majority of ambulatory patients with RA had active disease. Most of them were sub-optimally treated, especially the use of DMARDS. About two thirds were on oral steroids. Sub-optimal therapy in relatively young patients, peak 20-29 and 40-49 years is likely to impact negatively on their disease control and quality of life.
确定类风湿关节炎(RA)患者的社会人口统计学特征及一些临床方面情况。
前瞻性横断面研究。
肯尼亚国家医院(KNH)的门诊诊所,这是一家国立公立转诊医院。
在接受访谈和检查的180例患者中,60例符合美国风湿病学会(ACR)的RA诊断标准。
招募的60例患者中,52例(87%)为女性,男女比例为1:6.5。患者的平均年龄为41.38(±16.8)岁。发病年龄有两个高峰,分别为20 - 29岁和40 - 49岁。在75%的研究患者中,手部的一个或多个掌指关节受累。其他常见受累部位依次为——手腕、肘部、膝盖、脚踝以及肩部的肩肱关节,呈对称性。血清类风湿因子阳性率为78.9%,类风湿结节在13.3%的研究患者中出现。绝大多数患者(88%)患有活动性疾病,其中18%为轻度疾病,38%为中度活动,32%为重度疾病。只有12%的患者疾病处于缓解期。46.7%的研究患者至少使用了一种改变病情抗风湿药(DMARD),药物选择包括甲氨蝶呤、柳氮磺胺吡啶、羟氯喹和来氟米特。最常见的药物组合是甲氨蝶呤加泼尼松龙,占研究人群的30%;66.7%的患者使用口服泼尼松龙,25%的研究患者仅服用非甾体抗炎药(NSAIDS)。
绝大多数门诊RA患者患有活动性疾病。他们中的大多数治疗未达最佳效果,尤其是DMARDs的使用。约三分之二的患者使用口服类固醇。相对年轻患者(发病高峰在20 - 29岁和40 - 49岁)治疗未达最佳可能会对其疾病控制和生活质量产生负面影响。